Matching codes
Official code-level notes1
- Inclusion terms
- Long term (current) use of hydroxyurea
Official code-level notes3
- Inclusion terms
- Long term (current) use of raloxifene (Evista)
- Inclusion terms
- Long term (current) use of tamoxifen (Nolvadex)
- Inclusion terms
- Long term (current) use of toremifene (Fareston)
Official code-level notes3
- Inclusion terms
- Long term (current) use of anastrozole (Arimidex)
- Inclusion terms
- Long term (current) use of exemestane (Aromasin)
- Inclusion terms
- Long term (current) use of letrozole (Femara)
Official code-level notes6
- Inclusion terms
- Long term (current) use of estrogen receptor downregulators
- Inclusion terms
- Long term (current) use of fulvestrant (Faslodex)
- Inclusion terms
- Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
- Inclusion terms
- Long term (current) use of goserelin acetate (Zoladex)
- Inclusion terms
- Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
- Inclusion terms
- Long term (current) use of megestrol acetate (Megace)
Official code-level notes3
- Inclusion terms
- Long term (current) use of oral antidiabetic drugs
- Excludes 2
- long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
- Excludes 2
- long term (current) use of insulin (Z79.4)
Official code-level notes2
- Excludes 2
- long term (current) use of insulin (Z79.4)
- Excludes 2
- long term (current) use of oral hypoglycemic drugs (Z79.84)
Official code-level notes3
- Inclusion terms
- Long term (current) use of methadone for pain management
- Excludes 2
- methadone use NOS (F11.9-)
- Excludes 2
- use of methadone for treatment of heroin addiction (F11.2-)